Site-specific labeling of annexin V with F-18 for apoptosis imaging

被引:75
作者
Li, Xuehe [1 ]
Link, Jeanne M. [1 ]
Stekhova, Svetlana [1 ]
Yagle, Kevin J. [1 ]
Smito, Christina [2 ]
Krohn, Kenneth A. [1 ]
Tait, Jonathan F. [2 ]
机构
[1] Univ Washington, Med Ctr, Dept Radiol, Seattle, WA 98195 USA
[2] Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA
关键词
D O I
10.1021/bc800164d
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Annexin V is useful in detecting apoptotic cells by binding to phosphatidylserine (PS) that is exposed on the outer surface of the cell membrane during apoptosis. In this study, we examined the labeling of annexin V-128, a mutated form of annexin V that has a single cysteine residue at the NH2 terminus, with the thiol-selective reagent F-18-labeling agent N-[4-[(4-[F-18]fluorobenzylidene)aminooxy]butyl]maleimide ([F-18]FBABM). We also examined the cell binding affinity of the F-18-labeled annexin V-128 ([F-18]FAN-128). [F-18]FBABM was synthesized in two-step, one-pot method modified from literature procedure. (Toyokuni et al., Bioconjugate Chem. 2003, 14, 1253-1259). The average yield of [F-18]FBABM was 23 +/- 4% (n = 4, decay-corrected) and the specific activity was similar to 6000 Ci/mmol. The total synthesis time was similar to 92 min. The critical improvement of this study was identifying and then developing a purification method to remove an impurity N-[4-[(4-dimethylaminobenzyiidene)aminooxy]butyl]maleimide 4, whose presence dramatically decreased the yield of protein labeling. Conjugation of [F-18]FBABM with the thiol-containing annexin V-128 gave [F-18]FAN-128 in 37 +/- 9% yield (n = 4, decay corrected). Erythrocyte binding assay of [18F]FAN-128 showed that this modification of annexin V-128 did not compromise its membrane binding affinity. Thus, an in vivo investigation of [F-18]FAN-128 as an apoptosis imaging agent is warranted.
引用
收藏
页码:1684 / 1688
页数:5
相关论文
共 27 条
[1]  
Belhocine T, 2002, CLIN CANCER RES, V8, P2766
[2]   Labeling of low-density lipoproteins using the 18F-labeled thiol-reactive N-[6-(4-[18F]fluorobenzylidene)aminooxyhexyl]maleimide [J].
Berndt, Mathias ;
Pietzsch, Jens ;
Wuest, Frank .
NUCLEAR MEDICINE AND BIOLOGY, 2007, 34 (01) :5-15
[3]  
Blankenberg F, 2003, Q J NUCL MED, V47, P337
[4]   Apoptotic cell death: its implications for imaging in the next millennium [J].
Blankenberg, FG ;
Tait, JF ;
Strauss, HW .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (03) :359-367
[5]   In vivo monitoring of apoptosis [J].
Brauer, M .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (02) :323-331
[6]   A BRIEF SURVEY OF METHODS FOR PREPARING PROTEIN CONJUGATES WITH DYES, HAPTENS, AND CROSS-LINKING REAGENTS [J].
BRINKLEY, M .
BIOCONJUGATE CHEMISTRY, 1992, 3 (01) :2-13
[7]  
Bruin B., 2005, BIOCONJUGATE CHEM, V16, P406
[8]  
FADOK VA, 1992, J IMMUNOL, V148, P2207
[9]   Production of [F-18]fluoroannexin for imaging apoptosis with PET [J].
Grierson, JR ;
Yagle, KJ ;
Eary, JF ;
Tait, JF ;
Gibson, DF ;
Lewellen, B ;
Link, JM ;
Krohn, KA .
BIOCONJUGATE CHEMISTRY, 2004, 15 (02) :373-379
[10]   In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients [J].
Haas, RLM ;
de Jong, D ;
Olmos, RAV ;
Hoefnagel, CA ;
van Den Heuvel, I ;
Zerp, SF ;
Bartelink, H ;
Verheij, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (03) :782-787